ADVISOR LIVE® ON DEMAND WEBINAR
Advisor Live Webinar: Current State of Ethylene Oxide Sterilization and the Potential for Device Shortages
Lawsuits, legislative actions and the closure of three sterilization plants over the past year have raised concerns about the future availability of millions of medical devices that are sterilized using ethylene oxide (EtO). This chemical process is used to sterilize more than 50 percent of medical devices and at least one product sterilized by this method is used with every admitted patient.
Premier recently participated in a two-day public hearing convened by the FDA to discuss how to address challenges with ethylene oxide amid public pressures to reduce the risks associated with emissions of the carcinogenic gas while avoiding medical device shortages.
The Premier leader who testified to the FDA advisory committee’s expert panel will provide a debrief of the FDA meeting, review our latest findings and discuss the next steps in preventing supply disruption.
Premier recently participated in a two-day public hearing convened by the FDA to discuss how to address challenges with ethylene oxide amid public pressures to reduce the risks associated with emissions of the carcinogenic gas while avoiding medical device shortages.
The Premier leader who testified to the FDA advisory committee’s expert panel will provide a debrief of the FDA meeting, review our latest findings and discuss the next steps in preventing supply disruption.
SPEAKERS:
- Chaun Powell, Group Vice President of Strategic Supplier Engagement, Premier
This Advisor Live® presentation is open to the public.
CONTACT INFORMATION
Premier is committed to protecting the privacy and security of any personal information you provide to us. By clicking here, you understand and acknowledge that the personal information that you are submitting on this form is subject to Premier's privacy policy.
Privacy Policy